Enzalutamide in European and North American men participating in the AFFIRM trial

OBJECTIVE: To explore any differences in efficacy and safety outcomes between European (EU) (n = 684) and North American (NA) (n = 395) patients in the AFFIRM trial (NCT00974311). PATIENTS AND METHODS: Phase III, double-blind, placebo-controlled, multinational AFFIRM trial in men with metastatic cas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BJU Int
Main Authors: Merseburger, Axel S, Scher, Howard I, Bellmunt, Joaquim, Miller, Kurt, Mulders, Peter FA, Stenzl, Arnulf, Sternberg, Cora N, Fizazi, Karim, Hirmand, Mohammad, Franks, Billy, Haas, Gabriel P, de Bono, Johann, de Wit, Ronald
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons Ltd 2015
Assuntos:
Urological Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4312486/
https://ncbi.nlm.nih.gov/pubmed/25123978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.12898
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares